Asked by: Justin Madders (Labour - Ellesmere Port and Neston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions she has had with relevant stakeholders on tackling shortages of Etoricoxib.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department is aware that a supplier of etoricoxib 60 milligram tablets is experiencing a supply issue. We have been working with that supplier to address the issue, and resupply is expected in early May 2024. We have worked with alternative suppliers to ensure they can cover the gap in the market in the meantime.
The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as other countries around the world. There can be a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.
Whilst we can’t always prevent supply issues, the Department has well-established tools and processes to manage them, in order to mitigate risks to patients. We work closely with the pharmaceutical industry, NHS England, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help ensure patients continue to have access to suitable medicines when supply is disrupted.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to improve NHS England's handling of complaints made by (a) staff, (b) patients and (c) carers.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
On complaints made by patients and carers, we have worked closely with the Parliamentary and Health Service Ombudsman on their work to develop the NHS Complaint Standards. These standards set out how National Health Service organisations that handle NHS complaints, such as NHS England, should approach complaint handling to ensure they are handled and resolved effectively.
On complaints made by staff, NHS England has published information about how people can speak to NHS England’s Freedom to Speak Up Team. Whilst there is a network of over 1,000 local Freedom to Speak Up Guardians across healthcare in England to support staff in speaking up, the information published by NHS England makes it clear that staff across the NHS can speak up to NHS England about anything that gets in the way of patient care, or affects their working life. My Rt hon. Friend, the Secretary of State for Health and Social Care speaks regularly to NHS England about its performance, responsibilities, and activity, including complaints.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps is she taking to address defensive culture in the handling of NHS complaints.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
We have worked closely with the Parliamentary and Health Service Ombudsman on their work to develop the NHS Complaint Standards, which set out how organisations providing services in the National Health Service should approach complaint handling. The standards place a strong focus on several aspects of complaint handling to avoid defensiveness, including emphasising the importance of actively listening and demonstrating a clear understanding of what the main issues are for the complainant, as well as the outcomes they seek, being thorough and fair, and identifying suitable ways to put things right for people.
Asked by: Justin Madders (Labour - Ellesmere Port and Neston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions she has had with relevant stakeholders on tackling shortages of Ezetimibe.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department is aware of supply issues affecting several Ezetimibe suppliers. We are engaging with these suppliers to address the issues, and are working with alternative suppliers to ensure supplies remain available.
The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as other countries around the world. There can be a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.
Whilst we can’t always prevent supply issues, the Department has well-established tools and processes to manage them, in order to mitigate risks to patients. We work closely with the pharmaceutical industry, NHS England, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help ensure patients continue to have access to suitable medicines when supply is disrupted.
Asked by: Ellie Reeves (Labour - Lewisham West and Penge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her department is taking to improve retention rates of NHS maternity staff.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Long Term Workforce Plan sets out how to improve culture and leadership, to ensure that up to 130,000 fewer staff leave the National Health Service over the next 15 years. This includes: implementing actions from the NHS People Plan that have been shown to be successful; implementing plans to improve flexible opportunities for prospective retirees, and delivering the actions needed to modernise the NHS pension scheme; and committing to ongoing national funding for continuing professional development for nurses, midwives, and allied health professionals, so NHS staff are supported to meet their full potential. These measures apply across staff groups, including maternity staff.
Asked by: Bell Ribeiro-Addy (Labour - Streatham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to paragraph 4.2 of the report entitled A comparison of the care of Asian and White women who have experienced a stillbirth or neonatal death, published by the MBRRACE-UK Perinatal Confidential Enquiry on 14 December 2023, whether her Department has had discussions with NHS England on taking steps to improve how ethnicity data is recorded.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department has regular and ongoing discussions with NHS England, and other relevant bodies, on improving neonatal and maternity data quality. This includes discussions on how to improve the recording of ethnicity data. NHS Equity and Equality Guidance, produced as part of NHS England’s three-year delivery plan for maternity and neonatal services, includes ethnic coding data completeness to better understand local populations and their health outcomes. Ethnic coding data completeness has improved year on year, from 85% in 2019 to 93% in 2022.
Asked by: Justin Madders (Labour - Ellesmere Port and Neston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions she has had with stakeholders on tackling shortages of atorvastatin.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
There have been supply issues with atorvastatin, but as a result of our work to manage those issues, including engaging with alternative suppliers to cover supply gaps in order to meet demand, they have now been resolved.
The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as other countries around the world. There can be a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.
Whilst we can’t always prevent supply issues, the Department has well-established tools and processes to manage them, in order to mitigate risks to patients. We work closely with the pharmaceutical industry, NHS England, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help ensure patients continue to have access to suitable medicines when supply is disrupted.
Asked by: George Howarth (Labour - Knowsley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of discontinuing funding for T1DE pilot schemes on the health and well-being of patients living with type 1 diabetes with disordered eating.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England has provided funding for eight integrated care boards (ICBs) across the country to support the development and establishment of Type 1 Diabetes with Disordered Eating (T1DE) services in every National Health Service region. Funding has been provided on a pump prime basis, and the responsibility for the longer-term sustainable provision of care for these patients sits with the relevant integrated care system.
A nationally commissioned evaluation has shown the positive impact that the provision of T1DE services can have for patients, including reductions in HbA1c, which is linked to reduced rates of diabetes complications, and reduced rates of emergency admissions.
It’s the role of the ICBs to consider the health needs of their populations, in making decisions about the care that is provided. It is expected that ICB leads consider these evaluation findings alongside the risk to patient health and wellbeing of the discontinuation of service provision, as well as other local contextual factors in making decisions about the future provision of T1DE services.
Asked by: Adam Afriyie (Conservative - Windsor)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of her legislative proposals on vaping on trends in the level of (a) smokers who will quit and (b) ex-smokers who will relapse.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
The health advice on vaping is clear, if you don’t smoke, don’t vape, and children should never vape. However, youth vaping has tripled in the last three years, and one in five children have now used a vape.
The Tobacco and Vapes Bill will crack down on youth vaping by providing powers to regulate flavours, displays, and packaging for vapes and nicotine pouches. It will ban free vape samples being given to children, and introduce an age of sale for non-nicotine vapes.
In doing this, we must strike the right balance between reducing the appeal of vapes to children while ensuring vapes remain attractive and available to adult smokers as a quit aid. This will be carefully considered in the development of any specific restrictions, and further consultation will take place before introducing any regulations. As stated in Parliament during the second reading of the Tobacco and Vapes Bill, we intend to hold the consultation on the regulations before the end of this Parliament, if practicable. We will also undertake an impact assessment to consider the potential impact of these regulations on smokers as well as other groups.
Asked by: George Howarth (Labour - Knowsley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the rate of public satisfaction with the NHS was in (a) February 2024 or (b) the most recent month and year that data has been collected.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Data regarding the rate of public satisfaction with the National Health Service is publicly accessible, and is available at the following link:
https://yougov.co.uk/topics/politics/explore/institution/NHS
My Rt hon. Friend, the Secretary of State for Health and Social Care takes public perceptions of the NHS into account in her policy decisions. We have published recovery plans for elective services, urgent and emergency care, primary care and dental care, to improve access and performance of crucial NHS services.
Furthermore, we have made a great deal of progress in putting patients at the heart of care, through our recently announced programmes to expand choice, advanced care planning conversations, personal health budgets, and by providing more information to patients.